AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MONTELUKAST 5 Mg ;

10 registrations across 1 African market— 10 active

Markets with MONTELUKAST 5 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Inletair 5mg
Chewable Tablets
🇪🇬Egyptorgano for pharmaceutical and chemical industries (organo pharma)active
Statukast 5mg
Chewable Tablets
🇪🇬EgyptAdwiaactive
Montelosab 5 mg
Chewable Tablets
🇪🇬Egyptvercureactive
Statukast 5mg
Chewable Tablets
🇪🇬EgyptAdwiaactive
Montelosab 5 mg
Chewable Tablets
🇪🇬Egyptvercureactive
Montel 5mg
Chewable Tablets
🇪🇬EgyptEMA Pharm Pharmaceuticalsactive
Montasmawel 5 mg
Chewable Tablets
🇪🇬EgyptWadi El Neel Benta for Pharmaceuticals and Medical Devicesactive
Inletair 5mg
Chewable Tablets
🇪🇬Egyptorgano for pharmaceutical and chemical industries (organo pharma)active
Montel 5mg
Chewable Tablets
🇪🇬EgyptEMA Pharm Pharmaceuticalsactive
Montasmawel 5 mg
Chewable Tablets
🇪🇬EgyptWadi El Neel Benta for Pharmaceuticals and Medical Devicesactive

MONTELUKAST 5 Mg ; in Africa — Regulatory Overview

MONTELUKAST 5 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.